Inventor · disambiguated record
Bachra Rokbi
Also filed as: ROKBI BACHRA
14 granted patents·6 pending applications·19 citations·filing 1999–2024
88Inventor score
Top patents by PatentIndex Score
20 records- 0177US8309100B2Nucleic acids and polypeptides specific of the Neisseria genus pathogenic strainsAUJAME LUC·Filed 2010·Granted Nov 13, 2012·2 cites·6 claims
- 0276US9669052B2Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6SANOFI PASTEUR SA·Filed 2015·Granted Jun 6, 2017·1 cites·9 claims
- 0373US7704513B2Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genusAVENTIS PASTEUR·Filed 2008·Granted Apr 27, 2010·0 cites·6 claims
- 0472US9132181B2Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6MISTRETTA NOËLLE·Filed 2010·Granted Sep 15, 2015·1 cites·7 claims
- 0572US8338137B2Type 5 and type 8 capsular polysaccharides of overproducing S. aureus strainsROKBI BACHRA·Filed 2007·Granted Dec 25, 2012·5 cites·19 claims
- 0672US7863013B2Method for the production of overproducing Staphylococcus aureus strainsSANOFI PASTEUR S A·Filed 2006·Granted Jan 4, 2011·2 cites·4 claims
- 0772US7384768B2Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genusAVENTIS PASTEUR·Filed 2004·Granted Jun 10, 2008·2 cites·4 claims
- 0868US2025009865A1Combination respiratory mrna vaccinesSANOFI SA·Filed 2024·Application pending·0 cites
- 0964US2024415948A1Meningococcal b recombinant vaccineSANOFI PASTEUR INC·Filed 2024·Application pending·0 cites
- 1060US12053516B2Meningococcal B recombinant vaccineSANOFI PASTEUR INC·Filed 2022·Granted Aug 6, 2024·0 cites·15 claims
- 1159US10137145B2Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6MISTRETTA NOELLE·Filed 2017·Granted Nov 27, 2018·0 cites·12 claims
- 1259US2019117684A1Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6SANOFI PASTEUR SA·Filed 2018·Application pending·0 cites
- 1347US10772946B2Immunogenic compositions against S. aureusSANOFI PASTEUR·Filed 2016·Granted Sep 15, 2020·0 cites·32 claims
- 1445US8557537B2Method for the production of overproducing Staphylococcus aureus strainsROKBI BACHRA·Filed 2010·Granted Oct 15, 2013·0 cites·5 claims
- 1545US6835384B1Nucleic acids and polypeptides specific of the neisseria genus pathogenic strainsAVENTIS PASTEUR·Filed 1999·Granted Dec 28, 2004·6 cites·4 claims
- 1643US8673617B2Culture medium for Haemophilus influenzae type BMAITRE-WILMOTTE GHISLAINE·Filed 2008·Granted Mar 18, 2014·0 cites·23 claims
- 1740US10232029B2Compositions comprising N. meningitidis proteinsSANOFI PASTEUR·Filed 2015·Granted Mar 19, 2019·0 cites·31 claims
- 1834US2018125961A1Neisseria meningitidis trypsin-like serine protease polypeptides and compositions thereofSANOFI PASTEUR·Filed 2015·Application pending·0 cites
- 1933US2018125960A1Meningitidis vaccines comprising subtilinasesSANOFI PASTEUR·Filed 2015·Application pending·0 cites
- 2028US2012156281A1Meningococcal Vaccine Based on Lipooligosaccharide (LOS) and Neisseria Meningitidis ProteinHAENSLER JEAN·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →